| Veshal Malhotra, DO | |
|
8700 Beverly Blvd # 220, West Hollywood, CA 90048-1804 | |
| (310) 423-5252 | |
| Not Available |
| Full Name | Veshal Malhotra |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 10 Years |
| Location | 8700 Beverly Blvd # 220, West Hollywood, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023428380 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Tarzana Medical Center | Tarzana, CA | Hospital |
| Cedars-sinai Medical Center | Los angeles, CA | Hospital |
| Lake Balboa Care Center | Van nuys, CA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cedars-sinai Medical Care Foundation | 0941106645 | 1116 |
News Archive
SXC Health Solutions Corp. announced today the pricing of its previously announced public offering of common shares. Under the offering, SXC will sell 5,200,000 of its common shares at a price to the public of $90.60 per share.
A UT Arlington bioengineer has received a four-year, $1.4 million National Institutes of Health grant to create a nanoparticle system to shore up arterial walls following angioplasty and stenting procedures to treat coronary arterial disease.
Researchers at the University of Queensland have discovered that the thickness of the brain's outer layer influences how individual neurons process information.
TissueGnostics is pleased to announce achieving a new level of confidence within the international biomedical research community. As of May 2020, TissueGnostics has been referenced in over 1,500 individual research publications. High impact research made possible by TissueGnostics, emerging from 59 countries on 6 continents, results in a sum impact factor of 8,700.
› Verified 5 days ago
| Entity Name | Cedars-sinai Medical Care Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316984388 PECOS PAC ID: 0941106645 Enrollment ID: O20040202000464 |
News Archive
SXC Health Solutions Corp. announced today the pricing of its previously announced public offering of common shares. Under the offering, SXC will sell 5,200,000 of its common shares at a price to the public of $90.60 per share.
A UT Arlington bioengineer has received a four-year, $1.4 million National Institutes of Health grant to create a nanoparticle system to shore up arterial walls following angioplasty and stenting procedures to treat coronary arterial disease.
Researchers at the University of Queensland have discovered that the thickness of the brain's outer layer influences how individual neurons process information.
TissueGnostics is pleased to announce achieving a new level of confidence within the international biomedical research community. As of May 2020, TissueGnostics has been referenced in over 1,500 individual research publications. High impact research made possible by TissueGnostics, emerging from 59 countries on 6 continents, results in a sum impact factor of 8,700.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Veshal Malhotra, DO 4140 W 190th St, Torrance, CA 90504-5513 Ph: (310) 967-1782 | Veshal Malhotra, DO 8700 Beverly Blvd # 220, West Hollywood, CA 90048-1804 Ph: (310) 423-5252 |
News Archive
SXC Health Solutions Corp. announced today the pricing of its previously announced public offering of common shares. Under the offering, SXC will sell 5,200,000 of its common shares at a price to the public of $90.60 per share.
A UT Arlington bioengineer has received a four-year, $1.4 million National Institutes of Health grant to create a nanoparticle system to shore up arterial walls following angioplasty and stenting procedures to treat coronary arterial disease.
Researchers at the University of Queensland have discovered that the thickness of the brain's outer layer influences how individual neurons process information.
TissueGnostics is pleased to announce achieving a new level of confidence within the international biomedical research community. As of May 2020, TissueGnostics has been referenced in over 1,500 individual research publications. High impact research made possible by TissueGnostics, emerging from 59 countries on 6 continents, results in a sum impact factor of 8,700.
› Verified 5 days ago
Denise Jung, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd, West Hollywood, CA 90048 Phone: 310-423-5161 | |
Divya Narayanan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd Ste B220, West Hollywood, CA 90048 Phone: 310-423-5252 Fax: 310-423-8441 | |
Lili Barsky, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd Ste B220, West Hollywood, CA 90048 Phone: 310-423-5252 Fax: 310-423-8441 | |
Long-co Nguyen, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd # B220, West Hollywood, CA 90048 Phone: 310-423-5252 Fax: 310-423-8441 | |
Sherwin Kuo, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd # B220, West Hollywood, CA 90048 Phone: 310-423-5252 Fax: 310-423-8441 | |
Dr. Charmaine Dy-sy Reghitto, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd, West Hollywood, CA 90048 Phone: 310-423-5252 Fax: 310-423-8441 | |
Shaun Jason Miller, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd, B-220, West Hollywood, CA 90048 Phone: 310-423-5252 |